Medicine and Dentistry
Chronic Kidney Disease
100%
Blood Pressure
41%
ANCA Associated Vasculitis
32%
Endothelin 1
31%
Vasculitis
27%
Arterial Stiffness
25%
Cardiovascular Disease
25%
Nephropathy
24%
Endothelin
24%
Cardiovascular System
23%
Natriuresis
22%
Optical Coherence Tomography
22%
Table Salt
21%
Cardiovascular Risk
19%
Choroid
19%
Endothelin A Receptor
18%
Kidney Function
18%
Proteinuria
16%
Biological Marker
15%
Placebo
15%
Diseases
15%
Renal Biopsy
14%
Myocardial Infarction
13%
End Stage Renal Disease
13%
Endothelin Receptor Antagonist
13%
Endothelin Receptor
12%
Endothelial Dysfunction
11%
Clinical Study
11%
Volunteer
11%
Gene Linkage
11%
Apelin
10%
Insulin Dependent Diabetes Mellitus
10%
Cardiac Troponin
10%
Resuscitation
10%
Pulse Wave Velocity
10%
Receptor Blocking
9%
Sitaxentan
9%
Microcirculation
8%
Renal Failure
7%
Receptor
7%
Glomerular Filtration Rate
7%
Retinal Imaging
7%
Kidney Injury
7%
Creatinine
7%
Disease Activity
7%
Kidney Graft
6%
Public Health
6%
Endothelin System
6%
Glucocorticoid
6%
Neutrophil
6%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
65%
Endothelin
34%
Cardiovascular Disease
34%
Endothelin 1
28%
Cardiovascular Risk
17%
Placebo
17%
ANCA Associated Vasculitis
17%
Apelin
15%
Endothelin Receptor Antagonist
15%
Vasculitis
15%
Endothelin A Receptor
15%
End Stage Renal Disease
14%
Sitaxentan
13%
Creatinine
12%
Biological Marker
11%
Heart Infarction
10%
Kidney Disease
10%
Diseases
9%
Receptor
8%
Proteinuria
8%
Coronary Artery Disease
7%
Prevalence
7%
Normal Human
7%
Table Salt
7%
Clinical Research
7%
Endothelin Receptor
6%
Pulmonary Hypertension
6%
Cerebrovascular Accident
6%
Resistant Hypertension
6%
Kidney Failure
5%
Clinical Study
5%
Antihypertensive Agent
5%
Nifedipine
5%
Hemodialysis
5%
Diabetes Mellitus
5%
Inflammation
5%
Replacement Therapy
5%
Therapeutic Use
5%
Gold Nanoparticle
5%
Inductively Coupled Plasma
5%
Antiplatelet
5%
Ticagrelor
5%
microRNA 122
5%
Endothelin B Receptor
5%
Contrast Induced Nephropathy
5%
Proprotein Convertase 9
5%
Phosphodiesterase V Inhibitor
5%
Preclinical Study
5%
Bacterial Endocarditis
5%
Pharmacokinetics
5%